1. Home
  2. SYF vs VTRS Comparison

SYF vs VTRS Comparison

Compare SYF & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Synchrony Financial

SYF

Synchrony Financial

N/A

Current Price

$71.80

Market Cap

24.5B

Sector

Finance

ML Signal

N/A

Logo Viatris Inc.

VTRS

Viatris Inc.

N/A

Current Price

$21.05

Market Cap

21.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SYF
VTRS
Founded
1932
1961
Country
United States
United States
Employees
N/A
30000
Industry
Finance: Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.5B
21.0B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
SYF
VTRS
Price
$71.80
$21.05
Analyst Decision
Buy
Buy
Analyst Count
23
12
Target Price
★ $87.00
$21.00
AVG Volume (30 Days)
4.3M
★ 8.6M
Earning Date
10-20-2026
11-05-2026
Dividend Yield
1.90%
★ 2.30%
EPS Growth
★ 8.54
N/A
EPS
★ 7.52
N/A
Revenue
N/A
★ $14,299,900,000.00
Revenue This Year
$1.17
$3.53
Revenue Next Year
$5.11
$3.69
P/E Ratio
$9.56
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$63.08
$10.15
52 Week High
$88.77
$20.84

Technical Indicators

Market Signals
Indicator
SYF
VTRS
Relative Strength Index (RSI) 40.67 75.31
Support Level $69.23 $16.02
Resistance Level $75.01 N/A
Average True Range (ATR) 2.28 0.57
MACD -0.37 0.21
Stochastic Oscillator 25.60 98.45

Price Performance

Historical Comparison
SYF
VTRS

About SYF Synchrony Financial

Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.

Share on Social Networks: